BofA/Merrill Lynch Starts Aegerion Pharmaceuticals (AEGR) at Buy

March 5, 2013 7:13 AM EST
Get Alerts AEGR Hot Sheet
Price: $1.41 --0%

Rating Summary:
    11 Buy, 4 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 19 | New: 12
Trade AEGR Now!
Join SI Premium – FREE
BofA/Merrill Lynch initiates coverage on Aegerion Pharmaceuticals (NASDAQ: AEGR) with a Buy. PT $39.00.

For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.

Shares of Aegerion Pharmaceuticals closed at $32.52 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Merrill Lynch, Bank of America

Add Your Comment